The safety of lithium

JAMA Psychiatry

Volumn 72, Issue 12, 2015, Pages 1167-1169

  Goodwin, Guy M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; ANTICONVULSIVE AGENT;

BIPOLAR DISORDER; CHRONIC KIDNEY DISEASE; DRUG EXPOSURE; DRUG SAFETY; EDITORIAL; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; PRESCRIPTION; SUICIDE; CHEMICALLY INDUCED; RENAL INSUFFICIENCY, CHRONIC;

ANTICONVULSANTS; HUMANS; LITHIUM; RENAL INSUFFICIENCY, CHRONIC;

EID: 84948988606     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.2014     Document Type: Editorial

References (7)

1. Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study [published online November 4, 2015]. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2015.1834.
2. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012; 379 (9811): 165-180.
3. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012; 379 (9817): 721-728.
4. Close H, Reilly J, Mason JM, et al. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One. 2014; 9 (3): e90169.
5. AiffH, Attman PO, Aurell M, et al. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol. 2015; 29 (5): 608-614.
6. Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015; 386 (9992): 461-468.
7. Westman J, Hällgren J, Wahlbeck K, Erlinge D, Alfredsson L, Ösby U. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open. 2013; 3 (4): e002373.